Karolinska Development AB (publ)
STO: KDEV.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Viktor Drvota
- Employees
- 8
- Headquarters
- Solna, Sweden
- IPO year
- 2011
- Market cap
- SEK 67.5M
- Website
- https://www.karolinskadevelopment.com
Loading KDEV…
Loading profile data…Frequently asked questions about KDEV
What does Karolinska Development AB (publ) (KDEV.ST) do?
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools a...
Where does KDEV.ST trade?
Karolinska Development AB (publ) (KDEV.ST) trades on the Stockholm Stock Exchange.
What sector is KDEV.ST in?
Karolinska Development AB (publ) (KDEV.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Karolinska Development AB (publ)?
Viktor Drvota is the chief executive officer of Karolinska Development AB (publ) (KDEV.ST).
Where is Karolinska Development AB (publ) headquartered?
Karolinska Development AB (publ) is headquartered in Sweden.
Does KDEV.ST pay a dividend?
Karolinska Development AB (publ) (KDEV.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KDEV.ST go public?
Karolinska Development AB (publ) (KDEV.ST) completed its initial public offering in 2011.